MicroRNA-203 Expression as Potential Biomarker for Lupus Nephritis [Corrigendum]

Setyawan Y, Susianti H, Sulistyarti H, et al. Int J Nephrol Renovasc Dis. 2025;18:53—58. The authors have advised there is an error in affiliation 1 on page 53. The text “Doctoral Program in Biomedical Science” should read “Doctoral Program in Medical Sciences”. The authors apologize for this error.

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2025-04-01
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MicroRNA-203 Expression as Potential Biomarker for Lupus Nephritis [Corrigendum]

Dove Medical Press (Taylor and Francis Group)
MicroRNA in disease regulation
article

MicroRNA-203 Expression as Potential Biomarker for Lupus Nephritis [Corrigendum]

article en

Abstract

Setyawan Y, Susianti H, Sulistyarti H, et al. Int J Nephrol Renovasc Dis. 2025;18:53—58. The authors have advised there is an error in affiliation 1 on page 53. The text “Doctoral Program in Biomedical Science” should read “Doctoral Program in Medical Sciences”. The authors apologize for this error.

Dove Medical Press (Taylor and Francis Group)
Openalex Percentile: Top 42%
MicroRNA in disease regulation
Open Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

MicroRNA-203 Expression as Potential Biomarker for Lupus Nephritis [Corrigendum] · Dove Medical Press (Taylor and Francis Group) (2025) | TGRS Research Map | TGRS